nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—Nail changes—Etoposide—uterine cancer	0.0249	0.0501	CcSEcCtD
Floxuridine—Arterial thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.0237	0.0478	CcSEcCtD
Floxuridine—TYMP—myometrium—uterine cancer	0.0211	0.087	CbGeAlD
Floxuridine—TYMP—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0183	0.0777	CbGpPWpGaD
Floxuridine—TYMP—uterine cervix—uterine cancer	0.0164	0.0677	CbGeAlD
Floxuridine—TYMP—smooth muscle tissue—uterine cancer	0.0159	0.0658	CbGeAlD
Floxuridine—TYMS—G1/S-Specific Transcription—RRM2—uterine cancer	0.0159	0.0676	CbGpPWpGaD
Floxuridine—TYMP—decidua—uterine cancer	0.0156	0.0645	CbGeAlD
Floxuridine—TYMP—endometrium—uterine cancer	0.0148	0.0612	CbGeAlD
Floxuridine—TYMP—mammalian vulva—uterine cancer	0.0144	0.0592	CbGeAlD
Floxuridine—TYMS—uterine cervix—uterine cancer	0.0141	0.0581	CbGeAlD
Floxuridine—TYMS—smooth muscle tissue—uterine cancer	0.0137	0.0564	CbGeAlD
Floxuridine—TYMP—uterus—uterine cancer	0.0137	0.0564	CbGeAlD
Floxuridine—TYMS—endometrium—uterine cancer	0.0127	0.0525	CbGeAlD
Floxuridine—TYMS—mammalian vulva—uterine cancer	0.0123	0.0508	CbGeAlD
Floxuridine—TYMP—female reproductive system—uterine cancer	0.0123	0.0507	CbGeAlD
Floxuridine—Hepatic necrosis—Progesterone—uterine cancer	0.0121	0.0245	CcSEcCtD
Floxuridine—TYMP—female gonad—uterine cancer	0.0112	0.0461	CbGeAlD
Floxuridine—TYMP—vagina—uterine cancer	0.0111	0.0459	CbGeAlD
Floxuridine—Embolism—Progesterone—uterine cancer	0.011	0.0221	CcSEcCtD
Floxuridine—TYMS—female reproductive system—uterine cancer	0.0105	0.0435	CbGeAlD
Floxuridine—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.00996	0.0201	CcSEcCtD
Floxuridine—TYMS—female gonad—uterine cancer	0.00959	0.0396	CbGeAlD
Floxuridine—TYMS—vagina—uterine cancer	0.00954	0.0394	CbGeAlD
Floxuridine—Cladribine—RRM2—uterine cancer	0.00945	1	CrCbGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00935	0.0397	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.00935	0.0397	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00924	0.0393	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—RRM2—uterine cancer	0.00919	0.039	CbGpPWpGaD
Floxuridine—Abscess—Progesterone—uterine cancer	0.00892	0.018	CcSEcCtD
Floxuridine—TYMS—Podofilox—Etoposide—uterine cancer	0.00882	0.531	CbGdCrCtD
Floxuridine—Abscess—Medroxyprogesterone Acetate—uterine cancer	0.00808	0.0163	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDH1—uterine cancer	0.00751	0.0319	CbGpPWpGaD
Floxuridine—TYMP—lymph node—uterine cancer	0.00719	0.0297	CbGeAlD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—uterine cancer	0.00663	0.0282	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—ERBB2—uterine cancer	0.00634	0.0269	CbGpPWpGaD
Floxuridine—TYMS—lymph node—uterine cancer	0.00617	0.0255	CbGeAlD
Floxuridine—TYMP—Bladder Cancer—CXCL8—uterine cancer	0.00601	0.0255	CbGpPWpGaD
Floxuridine—Thrombophlebitis—Progesterone—uterine cancer	0.00592	0.0119	CcSEcCtD
Floxuridine—Gastroenteritis—Progesterone—uterine cancer	0.00578	0.0116	CcSEcCtD
Floxuridine—Disorientation—Progesterone—uterine cancer	0.00573	0.0115	CcSEcCtD
Floxuridine—Nail disorder—Etoposide—uterine cancer	0.00556	0.0112	CcSEcCtD
Floxuridine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00549	0.0111	CcSEcCtD
Floxuridine—TYMS—One Carbon Metabolism—MTHFR—uterine cancer	0.00539	0.0229	CbGpPWpGaD
Floxuridine—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00536	0.0108	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.00523	0.0222	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00512	0.0218	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RRM2—uterine cancer	0.00495	0.0211	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—VEGFA—uterine cancer	0.00488	0.0208	CbGpPWpGaD
Floxuridine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—uterine cancer	0.00485	0.0206	CbGpPWpGaD
Floxuridine—Infection—Carboplatin—uterine cancer	0.00476	0.00959	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00473	0.0201	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—RRM2—uterine cancer	0.0047	0.02	CbGpPWpGaD
Floxuridine—Cramp muscle—Progesterone—uterine cancer	0.00461	0.00929	CcSEcCtD
Floxuridine—TYMS—Danazol—Progesterone—uterine cancer	0.00454	0.273	CbGdCrCtD
Floxuridine—Gastritis—Progesterone—uterine cancer	0.00453	0.00913	CcSEcCtD
Floxuridine—Angina pectoris—Progesterone—uterine cancer	0.00431	0.00869	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.00431	0.0183	CbGpPWpGaD
Floxuridine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00425	0.00857	CcSEcCtD
Floxuridine—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00842	CcSEcCtD
Floxuridine—Body temperature increased—Carboplatin—uterine cancer	0.00379	0.00763	CcSEcCtD
Floxuridine—Lethargy—Dactinomycin—uterine cancer	0.00369	0.00744	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—TP53—uterine cancer	0.00369	0.0157	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—RRM2—uterine cancer	0.0036	0.0153	CbGpPWpGaD
Floxuridine—Haemoglobin—Progesterone—uterine cancer	0.00356	0.00718	CcSEcCtD
Floxuridine—Haemorrhage—Progesterone—uterine cancer	0.00354	0.00714	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—HRAS—uterine cancer	0.00353	0.015	CbGpPWpGaD
Floxuridine—Pharyngitis—Progesterone—uterine cancer	0.00352	0.00709	CcSEcCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—uterine cancer	0.00351	0.0149	CbGpPWpGaD
Floxuridine—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00349	0.00702	CcSEcCtD
Floxuridine—Lacrimation—Epirubicin—uterine cancer	0.00344	0.00693	CcSEcCtD
Floxuridine—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00337	0.0068	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—STAR—uterine cancer	0.00337	0.0143	CbGpPWpGaD
Floxuridine—Rash maculo-papular—Etoposide—uterine cancer	0.00328	0.00661	CcSEcCtD
Floxuridine—TYMS—Levonorgestrel—Progesterone—uterine cancer	0.00325	0.196	CbGdCrCtD
Floxuridine—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.0065	CcSEcCtD
Floxuridine—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00321	0.00647	CcSEcCtD
Floxuridine—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00642	CcSEcCtD
Floxuridine—Lacrimation—Doxorubicin—uterine cancer	0.00318	0.00641	CcSEcCtD
Floxuridine—Embolism—Epirubicin—uterine cancer	0.00315	0.00635	CcSEcCtD
Floxuridine—Alopecia—Progesterone—uterine cancer	0.00313	0.00631	CcSEcCtD
Floxuridine—Nail disorder—Epirubicin—uterine cancer	0.00312	0.00629	CcSEcCtD
Floxuridine—Erythema—Progesterone—uterine cancer	0.00308	0.00621	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.00303	0.0129	CbGpPWpGaD
Floxuridine—Pancytopenia—Dactinomycin—uterine cancer	0.00297	0.00599	CcSEcCtD
Floxuridine—Muscle spasms—Progesterone—uterine cancer	0.00297	0.00598	CcSEcCtD
Floxuridine—Embolism—Doxorubicin—uterine cancer	0.00292	0.00588	CcSEcCtD
Floxuridine—Nail disorder—Doxorubicin—uterine cancer	0.00289	0.00582	CcSEcCtD
Floxuridine—Ill-defined disorder—Progesterone—uterine cancer	0.00286	0.00577	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00286	0.0122	CbGpPWpGaD
Floxuridine—Anaemia—Progesterone—uterine cancer	0.00285	0.00574	CcSEcCtD
Floxuridine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00572	CcSEcCtD
Floxuridine—Nystagmus—Epirubicin—uterine cancer	0.00283	0.00571	CcSEcCtD
Floxuridine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00279	0.00563	CcSEcCtD
Floxuridine—Malaise—Progesterone—uterine cancer	0.00278	0.0056	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—HNF1B—uterine cancer	0.00275	0.0117	CbGpPWpGaD
Floxuridine—Stomatitis—Dactinomycin—uterine cancer	0.00272	0.00548	CcSEcCtD
Floxuridine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00269	0.00541	CcSEcCtD
Floxuridine—Nystagmus—Doxorubicin—uterine cancer	0.00262	0.00528	CcSEcCtD
Floxuridine—Agranulocytosis—Dactinomycin—uterine cancer	0.0026	0.00525	CcSEcCtD
Floxuridine—Discomfort—Progesterone—uterine cancer	0.00259	0.00523	CcSEcCtD
Floxuridine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.00523	CcSEcCtD
Floxuridine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00521	CcSEcCtD
Floxuridine—Abscess—Epirubicin—uterine cancer	0.00256	0.00515	CcSEcCtD
Floxuridine—Confusional state—Progesterone—uterine cancer	0.00254	0.00511	CcSEcCtD
Floxuridine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00508	CcSEcCtD
Floxuridine—Anaphylactic shock—Progesterone—uterine cancer	0.00252	0.00507	CcSEcCtD
Floxuridine—Infection—Progesterone—uterine cancer	0.0025	0.00504	CcSEcCtD
Floxuridine—Pharyngitis—Dactinomycin—uterine cancer	0.00249	0.00501	CcSEcCtD
Floxuridine—Nervous system disorder—Progesterone—uterine cancer	0.00247	0.00497	CcSEcCtD
Floxuridine—Anorexia—Progesterone—uterine cancer	0.0024	0.00483	CcSEcCtD
Floxuridine—Abscess—Doxorubicin—uterine cancer	0.00237	0.00477	CcSEcCtD
Floxuridine—Cramp muscle—Etoposide—uterine cancer	0.00236	0.00475	CcSEcCtD
Floxuridine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00474	CcSEcCtD
Floxuridine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00463	CcSEcCtD
Floxuridine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0046	CcSEcCtD
Floxuridine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.00457	CcSEcCtD
Floxuridine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00451	CcSEcCtD
Floxuridine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00223	0.0045	CcSEcCtD
Floxuridine—Alopecia—Dactinomycin—uterine cancer	0.00221	0.00446	CcSEcCtD
Floxuridine—Lacrimation increased—Epirubicin—uterine cancer	0.0022	0.00442	CcSEcCtD
Floxuridine—Glossitis—Epirubicin—uterine cancer	0.0022	0.00442	CcSEcCtD
Floxuridine—Decreased appetite—Progesterone—uterine cancer	0.00219	0.00441	CcSEcCtD
Floxuridine—Erythema—Dactinomycin—uterine cancer	0.00218	0.00439	CcSEcCtD
Floxuridine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00438	CcSEcCtD
Floxuridine—Pancytopenia—Etoposide—uterine cancer	0.00215	0.00433	CcSEcCtD
Floxuridine—Feeling abnormal—Progesterone—uterine cancer	0.00207	0.00418	CcSEcCtD
Floxuridine—Gastrointestinal pain—Progesterone—uterine cancer	0.00206	0.00415	CcSEcCtD
Floxuridine—Glossitis—Doxorubicin—uterine cancer	0.00203	0.00409	CcSEcCtD
Floxuridine—Lacrimation increased—Doxorubicin—uterine cancer	0.00203	0.00409	CcSEcCtD
Floxuridine—Ill-defined disorder—Dactinomycin—uterine cancer	0.00202	0.00408	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—uterine cancer	0.00201	0.00406	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—MLH3—uterine cancer	0.002	0.00852	CbGpPWpGaD
Floxuridine—Abdominal pain—Progesterone—uterine cancer	0.00199	0.00401	CcSEcCtD
Floxuridine—Body temperature increased—Progesterone—uterine cancer	0.00199	0.00401	CcSEcCtD
Floxuridine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.004	CcSEcCtD
Floxuridine—Stomatitis—Etoposide—uterine cancer	0.00197	0.00397	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—uterine cancer	0.00197	0.00396	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—uterine cancer	0.00195	0.00393	CcSEcCtD
Floxuridine—Agranulocytosis—Etoposide—uterine cancer	0.00188	0.0038	CcSEcCtD
Floxuridine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00379	CcSEcCtD
Floxuridine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00187	0.00376	CcSEcCtD
Floxuridine—Hypersensitivity—Progesterone—uterine cancer	0.00185	0.00374	CcSEcCtD
Floxuridine—Rash maculo-papular—Epirubicin—uterine cancer	0.00184	0.00371	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.00184	0.0078	CbGpPWpGaD
Floxuridine—Discomfort—Dactinomycin—uterine cancer	0.00183	0.00369	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.00183	0.00777	CbGpPWpGaD
Floxuridine—Asthenia—Progesterone—uterine cancer	0.00181	0.00364	CcSEcCtD
Floxuridine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00363	CcSEcCtD
Floxuridine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00363	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—uterine cancer	0.0018	0.00763	CbGpPWpGaD
Floxuridine—Infection—Dactinomycin—uterine cancer	0.00177	0.00356	CcSEcCtD
Floxuridine—TYMP—Metabolism—NDUFB11—uterine cancer	0.00176	0.0075	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—SRD5A2—uterine cancer	0.00176	0.0075	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—EZH2—uterine cancer	0.00176	0.00749	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00174	0.00351	CcSEcCtD
Floxuridine—Diarrhoea—Progesterone—uterine cancer	0.00172	0.00347	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—uterine cancer	0.00171	0.00726	CbGpPWpGaD
Floxuridine—Rash maculo-papular—Doxorubicin—uterine cancer	0.0017	0.00343	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.0017	0.00723	CbGpPWpGaD
Floxuridine—Thrombophlebitis—Epirubicin—uterine cancer	0.0017	0.00342	CcSEcCtD
Floxuridine—Anorexia—Dactinomycin—uterine cancer	0.0017	0.00342	CcSEcCtD
Floxuridine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00339	CcSEcCtD
Floxuridine—Photosensitivity—Epirubicin—uterine cancer	0.00167	0.00337	CcSEcCtD
Floxuridine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.0033	CcSEcCtD
Floxuridine—Alopecia—Etoposide—uterine cancer	0.0016	0.00323	CcSEcCtD
Floxuridine—Vomiting—Progesterone—uterine cancer	0.0016	0.00322	CcSEcCtD
Floxuridine—Rash—Progesterone—uterine cancer	0.00159	0.0032	CcSEcCtD
Floxuridine—Dermatitis—Progesterone—uterine cancer	0.00159	0.0032	CcSEcCtD
Floxuridine—Headache—Progesterone—uterine cancer	0.00158	0.00318	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—uterine cancer	0.00157	0.00316	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—NDC80—uterine cancer	0.00157	0.00666	CbGpPWpGaD
Floxuridine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00314	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—uterine cancer	0.00155	0.00312	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—uterine cancer	0.00155	0.00312	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.00154	0.00656	CbGpPWpGaD
Floxuridine—Muscle spasms—Etoposide—uterine cancer	0.00152	0.00306	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN1B—uterine cancer	0.00151	0.00643	CbGpPWpGaD
Floxuridine—Lethargy—Epirubicin—uterine cancer	0.0015	0.00302	CcSEcCtD
Floxuridine—Nausea—Progesterone—uterine cancer	0.0015	0.00301	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—uterine cancer	0.00147	0.00295	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—uterine cancer	0.00146	0.00295	CcSEcCtD
Floxuridine—Anaemia—Etoposide—uterine cancer	0.00146	0.00294	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00145	0.00293	CcSEcCtD
Floxuridine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00292	CcSEcCtD
Floxuridine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0029	CcSEcCtD
Floxuridine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0029	CcSEcCtD
Floxuridine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00288	CcSEcCtD
Floxuridine—Malaise—Etoposide—uterine cancer	0.00142	0.00287	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—uterine cancer	0.00141	0.00285	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—uterine cancer	0.00141	0.00283	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—uterine cancer	0.00141	0.00283	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—NDC80—uterine cancer	0.0014	0.00596	CbGpPWpGaD
Floxuridine—Lethargy—Doxorubicin—uterine cancer	0.00139	0.00279	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.00138	0.00588	CbGpPWpGaD
Floxuridine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00273	CcSEcCtD
Floxuridine—Dry skin—Epirubicin—uterine cancer	0.00135	0.00271	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—POLD1—uterine cancer	0.00133	0.00566	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—EP300—uterine cancer	0.00133	0.00565	CbGpPWpGaD
Floxuridine—Discomfort—Etoposide—uterine cancer	0.00133	0.00267	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.00132	0.00559	CbGpPWpGaD
Floxuridine—Hypersensitivity—Dactinomycin—uterine cancer	0.00131	0.00264	CcSEcCtD
Floxuridine—Gastritis—Epirubicin—uterine cancer	0.0013	0.00262	CcSEcCtD
Floxuridine—Confusional state—Etoposide—uterine cancer	0.0013	0.00262	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—uterine cancer	0.00129	0.00259	CcSEcCtD
Floxuridine—Infection—Etoposide—uterine cancer	0.00128	0.00258	CcSEcCtD
Floxuridine—Asthenia—Dactinomycin—uterine cancer	0.00128	0.00257	CcSEcCtD
Floxuridine—TYMP—Metabolism—AKR1B1—uterine cancer	0.00128	0.00542	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—STAR—uterine cancer	0.00128	0.00542	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Etoposide—uterine cancer	0.00126	0.00254	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—uterine cancer	0.00125	0.00251	CcSEcCtD
Floxuridine—Angina pectoris—Epirubicin—uterine cancer	0.00124	0.00249	CcSEcCtD
Floxuridine—Anorexia—Etoposide—uterine cancer	0.00123	0.00247	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—uterine cancer	0.00122	0.00245	CcSEcCtD
Floxuridine—Pancytopenia—Epirubicin—uterine cancer	0.00121	0.00243	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—uterine cancer	0.0012	0.00242	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—POLD1—uterine cancer	0.00119	0.00506	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00116	0.00233	CcSEcCtD
Floxuridine—Angina pectoris—Doxorubicin—uterine cancer	0.00114	0.00231	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—uterine cancer	0.00113	0.00228	CcSEcCtD
Floxuridine—Rash—Dactinomycin—uterine cancer	0.00112	0.00226	CcSEcCtD
Floxuridine—Decreased appetite—Etoposide—uterine cancer	0.00112	0.00226	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—uterine cancer	0.00112	0.00225	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	0.00111	0.00472	CbGpPWpGaD
Floxuridine—Stomatitis—Epirubicin—uterine cancer	0.0011	0.00222	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1B—uterine cancer	0.0011	0.00467	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00107	0.00216	CcSEcCtD
Floxuridine—Epistaxis—Epirubicin—uterine cancer	0.00107	0.00215	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—uterine cancer	0.00106	0.00214	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—uterine cancer	0.00106	0.00213	CcSEcCtD
Floxuridine—Agranulocytosis—Epirubicin—uterine cancer	0.00106	0.00213	CcSEcCtD
Floxuridine—Gastrointestinal pain—Etoposide—uterine cancer	0.00105	0.00212	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.00105	0.00444	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.00103	0.00438	CbGpPWpGaD
Floxuridine—Haemoglobin—Epirubicin—uterine cancer	0.00102	0.00206	CcSEcCtD
Floxuridine—Stomatitis—Doxorubicin—uterine cancer	0.00102	0.00206	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—uterine cancer	0.00102	0.00205	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—uterine cancer	0.00102	0.00205	CcSEcCtD
Floxuridine—Haemorrhage—Epirubicin—uterine cancer	0.00102	0.00205	CcSEcCtD
Floxuridine—Pharyngitis—Epirubicin—uterine cancer	0.00101	0.00203	CcSEcCtD
Floxuridine—TYMP—Metabolism—POLD1—uterine cancer	0.001	0.00425	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RRM2—uterine cancer	0.000994	0.00422	CbGpPWpGaD
Floxuridine—Epistaxis—Doxorubicin—uterine cancer	0.000988	0.00199	CcSEcCtD
Floxuridine—Agranulocytosis—Doxorubicin—uterine cancer	0.000977	0.00197	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—uterine cancer	0.000949	0.00191	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—uterine cancer	0.000945	0.0019	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—uterine cancer	0.00094	0.00189	CcSEcCtD
Floxuridine—TYMP—Metabolism—AKR1C1—uterine cancer	0.000936	0.00398	CbGpPWpGaD
Floxuridine—Pharyngitis—Doxorubicin—uterine cancer	0.000933	0.00188	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000926	0.00393	CbGpPWpGaD
Floxuridine—Asthenia—Etoposide—uterine cancer	0.000924	0.00186	CcSEcCtD
Floxuridine—TYMS—Metabolism—NDUFB11—uterine cancer	0.000903	0.00384	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—SRD5A2—uterine cancer	0.000903	0.00384	CbGpPWpGaD
Floxuridine—Alopecia—Epirubicin—uterine cancer	0.000898	0.00181	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000892	0.00379	CbGpPWpGaD
Floxuridine—Erythema—Epirubicin—uterine cancer	0.000884	0.00178	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—MLH1—uterine cancer	0.000882	0.00375	CbGpPWpGaD
Floxuridine—Diarrhoea—Etoposide—uterine cancer	0.000881	0.00178	CcSEcCtD
Floxuridine—Muscle spasms—Epirubicin—uterine cancer	0.00085	0.00171	CcSEcCtD
Floxuridine—TYMP—Metabolism—RRM2—uterine cancer	0.000834	0.00355	CbGpPWpGaD
Floxuridine—Alopecia—Doxorubicin—uterine cancer	0.000831	0.00167	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000827	0.00351	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Epirubicin—uterine cancer	0.000821	0.00165	CcSEcCtD
Floxuridine—Vomiting—Etoposide—uterine cancer	0.000819	0.00165	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—uterine cancer	0.000818	0.00165	CcSEcCtD
Floxuridine—Anaemia—Epirubicin—uterine cancer	0.000817	0.00165	CcSEcCtD
Floxuridine—Rash—Etoposide—uterine cancer	0.000812	0.00164	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—uterine cancer	0.000811	0.00163	CcSEcCtD
Floxuridine—TYMP—Metabolism—DCN—uterine cancer	0.00081	0.00344	CbGpPWpGaD
Floxuridine—Headache—Etoposide—uterine cancer	0.000807	0.00163	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—YWHAE—uterine cancer	0.000798	0.00339	CbGpPWpGaD
Floxuridine—Malaise—Epirubicin—uterine cancer	0.000798	0.00161	CcSEcCtD
Floxuridine—Leukopenia—Epirubicin—uterine cancer	0.000792	0.0016	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—uterine cancer	0.000787	0.00159	CcSEcCtD
Floxuridine—Nausea—Etoposide—uterine cancer	0.000765	0.00154	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP11A1—uterine cancer	0.000763	0.00324	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000759	0.00153	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000757	0.00322	CbGpPWpGaD
Floxuridine—Anaemia—Doxorubicin—uterine cancer	0.000756	0.00152	CcSEcCtD
Floxuridine—Discomfort—Epirubicin—uterine cancer	0.000744	0.0015	CcSEcCtD
Floxuridine—Malaise—Doxorubicin—uterine cancer	0.000738	0.00149	CcSEcCtD
Floxuridine—Leukopenia—Doxorubicin—uterine cancer	0.000733	0.00148	CcSEcCtD
Floxuridine—Confusional state—Epirubicin—uterine cancer	0.000728	0.00147	CcSEcCtD
Floxuridine—Anaphylactic shock—Epirubicin—uterine cancer	0.000722	0.00145	CcSEcCtD
Floxuridine—TYMP—Metabolism—AKR1C3—uterine cancer	0.000721	0.00306	CbGpPWpGaD
Floxuridine—Infection—Epirubicin—uterine cancer	0.000717	0.00144	CcSEcCtD
Floxuridine—Nervous system disorder—Epirubicin—uterine cancer	0.000708	0.00143	CcSEcCtD
Floxuridine—Thrombocytopenia—Epirubicin—uterine cancer	0.000707	0.00142	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000701	0.00298	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—uterine cancer	0.000688	0.00139	CcSEcCtD
Floxuridine—Anorexia—Epirubicin—uterine cancer	0.000688	0.00139	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—uterine cancer	0.000673	0.00136	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.00067	0.00285	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000668	0.00135	CcSEcCtD
Floxuridine—Infection—Doxorubicin—uterine cancer	0.000664	0.00134	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000662	0.00282	CbGpPWpGaD
Floxuridine—Nervous system disorder—Doxorubicin—uterine cancer	0.000655	0.00132	CcSEcCtD
Floxuridine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000654	0.00132	CcSEcCtD
Floxuridine—TYMS—Metabolism—STAR—uterine cancer	0.000653	0.00277	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKR1B1—uterine cancer	0.000653	0.00277	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000646	0.00274	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—uterine cancer	0.000637	0.00128	CcSEcCtD
Floxuridine—Decreased appetite—Epirubicin—uterine cancer	0.000627	0.00126	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—uterine cancer	0.00062	0.00263	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000616	0.00262	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2B—uterine cancer	0.000599	0.00255	CbGpPWpGaD
Floxuridine—Feeling abnormal—Epirubicin—uterine cancer	0.000595	0.0012	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—EP300—uterine cancer	0.000591	0.00251	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00059	0.00119	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000583	0.00248	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—uterine cancer	0.000581	0.00117	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000578	0.00246	CbGpPWpGaD
Floxuridine—Body temperature increased—Epirubicin—uterine cancer	0.000571	0.00115	CcSEcCtD
Floxuridine—Abdominal pain—Epirubicin—uterine cancer	0.000571	0.00115	CcSEcCtD
Floxuridine—TYMP—Metabolism—STK11—uterine cancer	0.000562	0.00239	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP19A1—uterine cancer	0.000562	0.00239	CbGpPWpGaD
Floxuridine—Feeling abnormal—Doxorubicin—uterine cancer	0.00055	0.00111	CcSEcCtD
Floxuridine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000546	0.0011	CcSEcCtD
Floxuridine—Hypersensitivity—Epirubicin—uterine cancer	0.000532	0.00107	CcSEcCtD
Floxuridine—Abdominal pain—Doxorubicin—uterine cancer	0.000528	0.00106	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—uterine cancer	0.000528	0.00106	CcSEcCtD
Floxuridine—Asthenia—Epirubicin—uterine cancer	0.000518	0.00104	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—BIRC5—uterine cancer	0.000517	0.0022	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—POLD1—uterine cancer	0.000512	0.00218	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000496	0.00211	CbGpPWpGaD
Floxuridine—Diarrhoea—Epirubicin—uterine cancer	0.000494	0.000995	CcSEcCtD
Floxuridine—Hypersensitivity—Doxorubicin—uterine cancer	0.000492	0.000991	CcSEcCtD
Floxuridine—Asthenia—Doxorubicin—uterine cancer	0.000479	0.000966	CcSEcCtD
Floxuridine—TYMS—Metabolism—AKR1C1—uterine cancer	0.000479	0.00204	CbGpPWpGaD
Floxuridine—Vomiting—Epirubicin—uterine cancer	0.000459	0.000925	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—uterine cancer	0.000457	0.000921	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000456	0.00194	CbGpPWpGaD
Floxuridine—Rash—Epirubicin—uterine cancer	0.000455	0.000917	CcSEcCtD
Floxuridine—Dermatitis—Epirubicin—uterine cancer	0.000455	0.000916	CcSEcCtD
Floxuridine—Headache—Epirubicin—uterine cancer	0.000452	0.000911	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000441	0.00187	CbGpPWpGaD
Floxuridine—Nausea—Epirubicin—uterine cancer	0.000429	0.000864	CcSEcCtD
Floxuridine—TYMS—Metabolism—RRM2—uterine cancer	0.000427	0.00181	CbGpPWpGaD
Floxuridine—Vomiting—Doxorubicin—uterine cancer	0.000425	0.000856	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—TP53—uterine cancer	0.000423	0.0018	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—MTHFR—uterine cancer	0.000422	0.00179	CbGpPWpGaD
Floxuridine—Rash—Doxorubicin—uterine cancer	0.000421	0.000849	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—uterine cancer	0.000421	0.000848	CcSEcCtD
Floxuridine—Headache—Doxorubicin—uterine cancer	0.000418	0.000843	CcSEcCtD
Floxuridine—TYMS—Metabolism—DCN—uterine cancer	0.000414	0.00176	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—uterine cancer	0.000397	0.000799	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP11A1—uterine cancer	0.00039	0.00166	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000383	0.00163	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000372	0.00158	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKR1C3—uterine cancer	0.000369	0.00157	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2A—uterine cancer	0.000343	0.00146	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000339	0.00144	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1B—uterine cancer	0.000304	0.00129	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	0.000298	0.00127	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—STK11—uterine cancer	0.000287	0.00122	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP19A1—uterine cancer	0.000287	0.00122	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—EP300—uterine cancer	0.000267	0.00113	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—uterine cancer	0.000235	0.000998	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—EP300—uterine cancer	0.000224	0.000951	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTHFR—uterine cancer	0.000216	0.000917	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—uterine cancer	0.000191	0.000811	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—uterine cancer	0.000166	0.000704	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—uterine cancer	0.000135	0.000575	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—uterine cancer	0.00012	0.00051	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—EP300—uterine cancer	0.000115	0.000487	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—uterine cancer	8.47e-05	0.00036	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—uterine cancer	6.92e-05	0.000294	CbGpPWpGaD
